NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

25.75

+0.54502.16%

Volume:307.00

Turnover:7.52K

Market Cap:2.90B

PE:- -

High:25.75

Open:23.80

Low:23.80

Close:25.20

52wk High:29.99

52wk Low:5.45

Shares:112.63M

Float Shares:112.63M

Volume Ratio:0.46

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

·

Yesterday

BRIEF-Newamsterdam Pharma Announces Positive Alzheimer’S Disease Data From Broadway Clinical Trial

Reuters

·

Jun 09

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NAMSW"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","latestPrice":25.745,"timestamp":1764968400000,"preClose":25.2,"halted":0,"volume":307,"delay":0,"floatShares":112628458,"shares":112628458,"eps":0,"marketStatus":"Market Closed","change":0.545,"latestTime":"12-05 16:00:00 EST","open":23.8,"high":25.745,"low":23.8,"amount":7520.55,"amplitude":0.077183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":25.2,"volumeRatio":0.4623494254427365},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","floatShares":112628458,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4623494254427365,"shares":112628458,"dividePrice":0,"high":25.745,"amplitude":0.077183,"preClose":25.2,"low":23.8,"week52Low":5.45,"pbRate":"--","week52High":29.99,"institutionHeld":0,"latestPrice":25.745,"eps":0,"divideRate":0,"volume":307,"delay":0,"ttmEps":0,"open":23.8,"prevYearClose":14.25,"prevWeekClose":29.7,"prevMonthClose":29.7,"prevQuarterClose":17.11,"fiveDayClose":29.7,"twentyDayClose":26.99,"sixtyDayClose":14.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMSW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMSW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMSW\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589817788","title":"NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2589817788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589817788?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:01","pubTimestamp":1764968460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUAB4VK7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMSW"],"gpt_icon":0},{"id":"2542389615","title":"BRIEF-Newamsterdam Pharma Announces Positive Alzheimer’S Disease Data From Broadway Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2542389615","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542389615?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:18","pubTimestamp":1749467898,"startTime":"0","endTime":"0","summary":"BRIEF-Newamsterdam Pharma Announces Positive Alzheimer’S Disease Data From Broadway Clinical TrialJune 9 (Reuters) - NewAmsterdam Pharma Company NV KH6.F:NEWAMSTERDAM PHARMA ANNOUNCES POSITIVE TOPLINE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nTUA2XTPRF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMSW"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NAMSW\",params:#limit:6,delay:false,,,undefined,":[]}}